Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits

Abstract Background As our understanding of gut microbiota’s metabolic impacts on health grows, the interest in engineered probiotics has intensified. This study aimed to engineer the probiotic Escherichia coli Nissle 1917 (EcN) to produce indoleacetic acid (IAA) in response to gut inflammatory biom...

Full description

Saved in:
Bibliographic Details
Main Authors: Seung-Gyun Woo, Seong Keun Kim, Seung-Goo Lee, Dae-Hee Lee
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Biological Engineering
Subjects:
Online Access:https://doi.org/10.1186/s13036-025-00479-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585658841956352
author Seung-Gyun Woo
Seong Keun Kim
Seung-Goo Lee
Dae-Hee Lee
author_facet Seung-Gyun Woo
Seong Keun Kim
Seung-Goo Lee
Dae-Hee Lee
author_sort Seung-Gyun Woo
collection DOAJ
description Abstract Background As our understanding of gut microbiota’s metabolic impacts on health grows, the interest in engineered probiotics has intensified. This study aimed to engineer the probiotic Escherichia coli Nissle 1917 (EcN) to produce indoleacetic acid (IAA) in response to gut inflammatory biomarkers thiosulfate and nitrate. Results Genetic circuits were developed to initiate IAA synthesis upon detecting inflammatory signals, optimizing a heterologous IAA biosynthetic pathway, and incorporating a RiboJ insulator to enhance IAA production. The engineered EcN strains demonstrated increased IAA production in the presence of thiosulfate and nitrate. An IAA-responsive genetic circuit using the IacR transcription factor from Pseudomonas putida 1290 was also developed for real-time IAA monitoring. Conclusions Given IAA’s role in reducing gastrointestinal inflammation, further refinement of this strain could lead to effective, in situ IAA-based therapies. This proof-of-concept advances the field of live biotherapeutic products and offers a promising approach for targeted therapy in inflammatory bowel diseases.
format Article
id doaj-art-aee88beb963f42528fd981a03f3be2d8
institution Kabale University
issn 1754-1611
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Biological Engineering
spelling doaj-art-aee88beb963f42528fd981a03f3be2d82025-01-26T12:37:29ZengBMCJournal of Biological Engineering1754-16112025-01-0119111210.1186/s13036-025-00479-yEngineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuitsSeung-Gyun Woo0Seong Keun Kim1Seung-Goo Lee2Dae-Hee Lee3Synthetic Biology Research Center and the K-Biofoundry, Korea Research Institute of Bioscience and Biotechnology (KRIBB)Synthetic Biology Research Center and the K-Biofoundry, Korea Research Institute of Bioscience and Biotechnology (KRIBB)Synthetic Biology Research Center and the K-Biofoundry, Korea Research Institute of Bioscience and Biotechnology (KRIBB)Synthetic Biology Research Center and the K-Biofoundry, Korea Research Institute of Bioscience and Biotechnology (KRIBB)Abstract Background As our understanding of gut microbiota’s metabolic impacts on health grows, the interest in engineered probiotics has intensified. This study aimed to engineer the probiotic Escherichia coli Nissle 1917 (EcN) to produce indoleacetic acid (IAA) in response to gut inflammatory biomarkers thiosulfate and nitrate. Results Genetic circuits were developed to initiate IAA synthesis upon detecting inflammatory signals, optimizing a heterologous IAA biosynthetic pathway, and incorporating a RiboJ insulator to enhance IAA production. The engineered EcN strains demonstrated increased IAA production in the presence of thiosulfate and nitrate. An IAA-responsive genetic circuit using the IacR transcription factor from Pseudomonas putida 1290 was also developed for real-time IAA monitoring. Conclusions Given IAA’s role in reducing gastrointestinal inflammation, further refinement of this strain could lead to effective, in situ IAA-based therapies. This proof-of-concept advances the field of live biotherapeutic products and offers a promising approach for targeted therapy in inflammatory bowel diseases.https://doi.org/10.1186/s13036-025-00479-yEscherichia coli Nissle 1917Inflammatory bowel diseaseIndoleacetic acidRiboJ insulatorGenetic circuit
spellingShingle Seung-Gyun Woo
Seong Keun Kim
Seung-Goo Lee
Dae-Hee Lee
Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits
Journal of Biological Engineering
Escherichia coli Nissle 1917
Inflammatory bowel disease
Indoleacetic acid
RiboJ insulator
Genetic circuit
title Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits
title_full Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits
title_fullStr Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits
title_full_unstemmed Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits
title_short Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits
title_sort engineering probiotic escherichia coli for inflammation responsive indoleacetic acid production using riboj enhanced genetic circuits
topic Escherichia coli Nissle 1917
Inflammatory bowel disease
Indoleacetic acid
RiboJ insulator
Genetic circuit
url https://doi.org/10.1186/s13036-025-00479-y
work_keys_str_mv AT seunggyunwoo engineeringprobioticescherichiacoliforinflammationresponsiveindoleaceticacidproductionusingribojenhancedgeneticcircuits
AT seongkeunkim engineeringprobioticescherichiacoliforinflammationresponsiveindoleaceticacidproductionusingribojenhancedgeneticcircuits
AT seunggoolee engineeringprobioticescherichiacoliforinflammationresponsiveindoleaceticacidproductionusingribojenhancedgeneticcircuits
AT daeheelee engineeringprobioticescherichiacoliforinflammationresponsiveindoleaceticacidproductionusingribojenhancedgeneticcircuits